Cargando…
Pulsed-laser irradiation of multifunctional gold nanoshells to overcome trastuzumab resistance in HER2-overexpressing breast cancer
BACKGROUND: HER2-overexpressing metastatic breast cancers are challenging practice in oncology when they become resistant to anti-HER2 therapies such as trastuzumab. In these clinical situations, HER2-overexpression persists in metastatic localizations, and can thus be used for active targeting usin...
Autores principales: | Nunes, Toni, Pons, Thomas, Hou, Xue, Van Do, Khanh, Caron, Benoît, Rigal, Marthe, Di Benedetto, Mélanie, Palpant, Bruno, Leboeuf, Christophe, Janin, Anne, Bousquet, Guilhem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6626398/ https://www.ncbi.nlm.nih.gov/pubmed/31299997 http://dx.doi.org/10.1186/s13046-019-1305-x |
Ejemplares similares
-
Targeting Cancer Stem Cells to Overcome Chemoresistance
por: Nunes, Toni, et al.
Publicado: (2018) -
Neratinib overcomes trastuzumab resistance in HER2 amplified breast cancer
por: Canonici, Alexandra, et al.
Publicado: (2013) -
Re‐exploring immune‐related side effects of docetaxel in an observational study: Blood hypereosinophilia
por: Hamdan, Diaddin, et al.
Publicado: (2019) -
Combining CD47 blockade with trastuzumab eliminates HER2-positive breast cancer cells and overcomes trastuzumab tolerance
por: Upton, Rosalynd, et al.
Publicado: (2021) -
Genomics applied to the treatment of breast cancer
por: Hamdan, Diaddin, et al.
Publicado: (2019)